All YP05002 articles
-
NewsPfizer boosts its obesity plans with $2bn GLP-1 YaoPharma deal
The move builds on its recent billion-dollar acquisition of the obesity-focused biopharma company Metsera.
The move builds on its recent billion-dollar acquisition of the obesity-focused biopharma company Metsera.